146 related articles for article (PubMed ID: 25156534)
1. Keratin 19 expression correlates with poor prognosis in breast cancer.
Kabir NN; Rönnstrand L; Kazi JU
Mol Biol Rep; 2014 Dec; 41(12):7729-35. PubMed ID: 25156534
[TBL] [Abstract][Full Text] [Related]
2. KRT19 and CEACAM5 mRNA-marked circulated tumor cells indicate unfavorable prognosis of breast cancer patients.
Wang XM; Zhang Z; Pan LH; Cao XC; Xiao C
Breast Cancer Res Treat; 2019 Apr; 174(2):375-385. PubMed ID: 30535933
[TBL] [Abstract][Full Text] [Related]
3. KRT19 directly interacts with β-catenin/RAC1 complex to regulate NUMB-dependent NOTCH signaling pathway and breast cancer properties.
Saha SK; Choi HY; Kim BW; Dayem AA; Yang GM; Kim KS; Yin YF; Cho SG
Oncogene; 2017 Jan; 36(3):332-349. PubMed ID: 27345400
[TBL] [Abstract][Full Text] [Related]
4. Cytokeratin 19
Saha SK; Kim K; Yang GM; Choi HY; Cho SG
Int J Mol Sci; 2018 May; 19(5):. PubMed ID: 29747452
[TBL] [Abstract][Full Text] [Related]
5. KRT8 and KRT19, associated with EMT, are hypomethylated and overexpressed in lung adenocarcinoma and link to unfavorable prognosis.
Wang W; He J; Lu H; Kong Q; Lin S
Biosci Rep; 2020 Jul; 40(7):. PubMed ID: 32519739
[TBL] [Abstract][Full Text] [Related]
6. Detection of circulating tumor cells in breast cancer patients using multiplex reverse transcription-polymerase chain reaction and specific primers for MGB, PTHRP and KRT19 correlation with clinicopathological features.
Skondra M; Gkioka E; Kostakis ID; Pissimissis N; Lembessis P; Pectasides D; Koutsilieris M
Anticancer Res; 2014 Nov; 34(11):6691-9. PubMed ID: 25368276
[TBL] [Abstract][Full Text] [Related]
7. Regulation of cell proliferation and migration by keratin19-induced nuclear import of early growth response-1 in breast cancer cells.
Ju JH; Yang W; Lee KM; Oh S; Nam K; Shim S; Shin SY; Gye MC; Chu IS; Shin I
Clin Cancer Res; 2013 Aug; 19(16):4335-46. PubMed ID: 23833298
[TBL] [Abstract][Full Text] [Related]
8. Keratin 18 is an integral part of the intermediate filament network in murine skeletal muscle.
Muriel JM; O'Neill A; Kerr JP; Kleinhans-Welte E; Lovering RM; Bloch RJ
Am J Physiol Cell Physiol; 2020 Jan; 318(1):C215-C224. PubMed ID: 31721615
[TBL] [Abstract][Full Text] [Related]
9. [Application of suspension array assay to detect marker genes expression of circulating tumor cells for early prediction of breast cancer metastasis].
Ke F; Wu JM; Yao JE; Bai YJ; Guo AL
Zhonghua Yi Xue Za Zhi; 2007 Aug; 87(32):2257-61. PubMed ID: 18001545
[TBL] [Abstract][Full Text] [Related]
10. Meta-analysis of gene expression profiles in breast cancer: toward a unified understanding of breast cancer subtyping and prognosis signatures.
Wirapati P; Sotiriou C; Kunkel S; Farmer P; Pradervand S; Haibe-Kains B; Desmedt C; Ignatiadis M; Sengstag T; Schütz F; Goldstein DR; Piccart M; Delorenzi M
Breast Cancer Res; 2008; 10(4):R65. PubMed ID: 18662380
[TBL] [Abstract][Full Text] [Related]
11. Interaction of cytokeratin 19 head domain and HER2 in the cytoplasm leads to activation of HER2-Erk pathway.
Ohtsuka T; Sakaguchi M; Yamamoto H; Tomida S; Takata K; Shien K; Hashida S; Miyata-Takata T; Watanabe M; Suzawa K; Soh J; Youyi C; Sato H; Namba K; Torigoe H; Tsukuda K; Yoshino T; Miyoshi S; Toyooka S
Sci Rep; 2016 Dec; 6():39557. PubMed ID: 28008968
[TBL] [Abstract][Full Text] [Related]
12. A Comprehensive Analysis of KRT19 Combined with Immune Infiltration to Predict Breast Cancer Prognosis.
Mi L; Liang N; Sun H
Genes (Basel); 2022 Oct; 13(10):. PubMed ID: 36292723
[TBL] [Abstract][Full Text] [Related]
13. Gene profiling and circulating tumor cells as biomarker to prognostic of patients with locoregional breast cancer.
Kuniyoshi RK; Gehrke Fde S; Alves BC; Vilas-Bôas V; Coló AE; Sousa N; Nunes J; Fonseca FL; Del Giglio A
Tumour Biol; 2015 Sep; 36(10):8075-83. PubMed ID: 25976504
[TBL] [Abstract][Full Text] [Related]
14. Differential expression of the miR-17-92 cluster and miR-17 family in breast cancer according to tumor type; results from the Norwegian Women and Cancer (NOWAC) study.
Moi L; Braaten T; Al-Shibli K; Lund E; Busund LR
J Transl Med; 2019 Oct; 17(1):334. PubMed ID: 31581940
[TBL] [Abstract][Full Text] [Related]
15. Keratin 19 Expression in Hepatocellular Carcinoma Is Regulated by Fibroblast-Derived HGF via a MET-ERK1/2-AP1 and SP1 Axis.
Rhee H; Kim HY; Choi JH; Woo HG; Yoo JE; Nahm JH; Choi JS; Park YN
Cancer Res; 2018 Apr; 78(7):1619-1631. PubMed ID: 29363547
[TBL] [Abstract][Full Text] [Related]
16. Association of GATA3, P53, Ki67 status and vascular peritumoral invasion are strongly prognostic in luminal breast cancer.
Jacquemier J; Charafe-Jauffret E; Monville F; Esterni B; Extra JM; Houvenaeghel G; Xerri L; Bertucci F; Birnbaum D
Breast Cancer Res; 2009; 11(2):R23. PubMed ID: 19405945
[TBL] [Abstract][Full Text] [Related]
17. The oestrogen receptor coactivator CARM1 has an oncogenic effect and is associated with poor prognosis in breast cancer.
Habashy HO; Rakha EA; Ellis IO; Powe DG
Breast Cancer Res Treat; 2013 Jul; 140(2):307-16. PubMed ID: 23887673
[TBL] [Abstract][Full Text] [Related]
18. A hedgehog pathway-dependent gene signature is associated with poor clinical outcomes in Luminal A breast cancer.
Rudolph M; Sizemore ST; Lu Y; Teng KY; Basree MM; Reinbolt R; Timmers CD; Leone G; Ostrowski MC; Majumder S; Ramaswamy B
Breast Cancer Res Treat; 2018 Jun; 169(3):457-467. PubMed ID: 29464534
[TBL] [Abstract][Full Text] [Related]
19. Gene expression analysis of embryonic pancreas development master regulators and terminal cell fate markers in resected pancreatic cancer: A correlation with clinical outcome.
Dugnani E; Sordi V; Pellegrini S; Chimienti R; Marzinotto I; Pasquale V; Liberati D; Balzano G; Doglioni C; Reni M; Gandolfi A; Falconi M; Lampasona V; Piemonti L
Pancreatology; 2018 Dec; 18(8):945-953. PubMed ID: 30293872
[TBL] [Abstract][Full Text] [Related]
20. Quantitative hormone receptor (HR) expression and gene expression analysis in HR+ inflammatory breast cancer (IBC) vs non-IBC.
Iwase T; Harano K; Masuda H; Kida K; Hess KR; Wang Y; Dirix L; Van Laere SJ; Lucci A; Krishnamurthy S; Woodward WA; Layman RM; Bertucci F; Ueno NT
BMC Cancer; 2020 May; 20(1):430. PubMed ID: 32423453
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
